Is anti-ageing therapy medical fiction? by Cilia-Vincenti, Albert
the quest for an immortality elixir has been around for centuries. Is anti-ageing, regenerative medical intervention, still in the realm of science fiction? We’re not talking of cosmetic 
surgery here, obviously. Some scientists believe that human 
immortality is possible in the future. If all our tissues have stem 
cells for replacement of worn out ones, why do we age and die? 
Even if immortality is not ultimately possible, are there any recent 
advances in understanding ageing and deteriorating function at 
cellular level? Extending useful, healthy life without added strains 
on health systems, would be a significant medical advance.
For some time we believed that longevity was directly related 
to the telomeres at both ends of chromosomes and that the rate 
they wear down determined longevity. A more recent theory 
explains the ageing process in terms of the deterioration of the 
process by which aged, worn-out, senescent cells are removed to 
make way for stem cell-derived new ones.
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In young tissues, senescent cells are quickly broken down 
and their constituent parts taken up and used by surrounding 
healthy cells by the combined processes of apoptosis 
(programmed cell death) and autophagy, in a similar way that an 
old car is dismantled and many of its parts used in other cars.
It appears that the organ changes we associate with ageing 
are related to an accumulation of senescent cells, which secrete 
protein-degrading enzymes that damage nearby healthy cells 
and produce chronic low-grade inflammation, damaging 
mitochondria and DNA and causing telomere dysfunction.1-4
Senescent cells also damage stem cells, limiting a tissue’s 
regenerative capacity.5 If accumulation of senescent cells causes 
age-associated diseases, could their removal improve health and 
slow ageing? We now have laboratory animal studies answering 
that question in the affirmative.
For the first time, it has been possible to remove senescent 
cells to make way for stem cells to replace them with new ones. 
The compounds used are now called senolytics. Mayo Clinic 
researchers, in a series of elegant experiments, have made 
almost unbelievable discoveries about the impact of senescent 
cells on normal healthy tissue.1,3 They found that transplanting 
just a few senescent cells into young mice triggered accelerated 
ageing processes seen in older animals. The greater the number 
of senescent cells, the greater the deterioration.1 Also, just a few 
senescent cells produced a snowball effect, triggering senescence 
in a large number of previously healthy cells. Senescent cells 
accelerated the ageing process and its associated problems.
Interestingly, a high-fat diet appeared to amplify the negative 
impact of senescent cells. With the mice on such a diet, even 
fewer senescent cells were needed to produce age-related 
ailments. It had been known that a high-fat diet and obesity 
induced cellular senescent in laboratory animals. But a dramatic 
finding was that the mice with senescent cells had a 5-fold 
higher risk of death compared to control mice.1
The researchers sought a solution to this identified 
senescent cell problem by testing a combination of two 
compounds with senolytic action, quercetin – a flavonoid 
found in apples, onions and other plants – and dasatinib, 
a tyrosine kinase inhibitor licensed for myeloid leukaemia 
treatment. This combination had a remarkable senolytic 
action, reducing senescent cell numbers and decreasing their 
production of proinflammatory signalling factors.6
When elderly mice were given the senolytic combination 
for four months, it increased their walking speed, improved 
their endurance, boosted grip strength and enhanced daily 
activity levels.
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Giving the senolytics to elderly mice also increased 
their life span by 36% and reduced their risk of dying by 
65%, compared to controls. The animals lived longer and 
healthier. The Mayo Clinic researchers referred to this result as 
“remarkable”, indicating that senolytics can improve survival 
and reduce overall disability – with interesting potential 
implications for humans.
A second Mayo Clinic study focused on another serious 
consequence of ageing – dementia.3 A strain of mice bred to 
produce tau protein was used. Tau protein build-up in the 
brain is a structural hallmark of Alzheimer’s disease, and 
this animal model exhibited high levels of neurofibrillary 
tangles, neurodegeneration and loss of cognitive function by 
early middle-age.3
The presence of senescent cells in the brain was found to 
increase neurodegeneration and, the larger the number of 
senescent cells, the higher the levels of tau and neurofibrillary 
tangles. The brain size was also smaller with marked neuronal 
degeneration in the hippocampal memory centre.
Amazingly, the combination quercetin-dasatinib senolytic 
agent was found to remove these senescent cells from the brain, 
including the hippocampus, with a consequent reduction of 
neurofibrillary tangles and tau aggregation. Removing the 
senescent cells lessened short-term memory loss and prevented 
the neurodegeneration seen in control untreated animals.
These remarkable findings in an animal model will inevitably 
trigger pharmaceutical research into safe anti-ageing senolytic 
drugs for humans. Extrapolation of the animal experiment 
results to humans would suggest an average healthy lifespan of 
110 years and beyond. 
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